BBC meeting

BBC4 Invited speakers

 

Dr Elena Aikawa (Brigham and Women’s Hospital, Harvard Medical School, Boston, USA)

  • Dr. Aikawa’s research program focuses on the development of new therapies to prevent, treat and cure calcific aortic valve stenosis, a disease that currently has no treatment options other than valve replacement. More…
 
Dr Magnus Back (Karolinska University Hospital, Stockholm, Sweden)

  • Dr Magnus Back’s research focuses on how ischemic heart disease and valvular heart disease occur and how knowledge of the di­sease mechanisms can be used in a clinical setting. More…
 
Dr Jacob Bentzon (Aarhus University, Denmark)
  • Dr Bentzon’s laboratory is studying the mechanisms of atherosclerosis formation by trying to understand how local smooth muscle cells in the arterial wall transform their phenotype and construct the fibrotic and calcified tissue of developing lesions. More…
 
Pr Bertrand Cariou (Nantes Université, France)

  • Pr. Cariou’s research focuses mainly on identifying the function of PCSK9 and aims to identify new targets in LDL-cholesterol metabolism. More…
 
Dr Marie-Annick Clavel (Université de Laval, Canada)

  • Dr Clavel’s research program objectives are to elucidate the differences gender in pathophysiology, clinical presentation, diagnosis and fate in patients with heart valve disease and especially aortic stenosis. More…
 
Pr Vanessa Dubois (Ghent University, Belgium)

  •  Pr. Vanessa Dubois studies sex hormone signaling in non-reproductive target tissues including liver and bone. More…
 
Pr Matthias Gunzer (University of Duisburg-Essen, Germany)

  • Pr Gunzer’s group is interested in characterizing the dynamics of immune cell behaviour, their motility and migratory pattern as well as formation of cell-cell interaction within the course of the immune response in vivo. More…
 
Dr Lucie Hénaut (University of Picardie Jules Verne, Amiens, France)

  • Dr Hénaut main’s interest is to better understand the mechanisms underlying the development of cardiovascular calcifications, especially in patients with chronic kidney disease. More…
 
Dr Annika Keller (University of Zürich, Switzerland)

  • Dr. Annika Keller’s group studies the development, function and dysfunction of the neurovascular unit in health and disease with the aim to understand the role of the individual cells (e.g. microglia, pericytes, astrocytes). More…
 
Dr Marie-Hélène Lafage-Proust (Inserm U1059 SAINBIOSE, St Etienne, France)
  • Dr Lafage-Proust is an expert in bone vascularisation and its role in bone remodeling. She developed tools to assess functional and morphological features of bone vessels in rodents, and is currently working on the involvement of bone microangiopathy in diabetes-related bone fragility. As a physician, she is focused on Bone and Mineral Disorders in Chronic Kidney Disease. More…
 
Dr Laurent Beck  (Inserm UMR1229 RMeS, Nantes Université, France)

  • Dr Beck’s group aims to better understand the fundamental aspects of skeletal physiology and pathophysiology in humans and mice by studying the relationships between bone/cartilage tissues and other important tissues present in the skeleton: vessels and adipocytes. More…
 
Dr Thibaut Quillard (Inserm UMR1087, Nantes Université, France)

  • Dr Quillard’s group study the phenotypic switch of endothelial and smooth muscle cell dysfunction between arterial beds and its implication in atherosclerosis heterogeneity, as well as the impact of hemodynamics on smooth muscle cell phenotype. More…
 

 

To view the invited speakers to BBC 1, 2 & 3, please visit this page.